Page last updated: 2024-08-24

tenofovir and Central Nervous System Diseases

tenofovir has been researched along with Central Nervous System Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blennow, K; Das, M; Gisslen, M; Hermansson, L; Makadzange, T; McCallister, S; Nilsson, S; Price, RW; Yilmaz, A; Zetterberg, H1
Castro, L; Chow, DC; Duerler, T; Gangcuangco, LMA; Kallianpur, KJ; Kohorn, L; Nagamine, L; Nakamoto, BK; Paul, R; Pien, FD; Shikuma, CM; Soll, B; Souza, S; Walker, M1

Trials

1 trial(s) available for tenofovir and Central Nervous System Diseases

ArticleYear
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Central Nervous System Diseases; Creatinine; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Middle Aged; Neurofilament Proteins; Tenofovir

2019

Other Studies

1 other study(ies) available for tenofovir and Central Nervous System Diseases

ArticleYear
Sleep and neuropsychological performance in HIV+ subjects on efavirenz-based therapy and response to switch in therapy.
    HIV clinical trials, 2018, Volume: 19, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cobicistat; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Sleep Wake Disorders; Tenofovir

2018